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This 1998 workshop was convened to address
the health risks of exposure to environmental
tobacco smoke (ETS) in the workplace. It was
paired with a 1997 workshop on issues related
to ETS exposure in work environments (1).
In the 1998 workshop, a multidisciplinary
group of participants was charged with
reviewing evidence on the quantitative risks to
health posed by ETS and to discuss develop-
ment of risk assessment methodology for the
future. The overall charges for the present
workshop were
* to consider various health outcomes and
make recommendations regarding those
health outcomes to be included in assess-
ment ofhealth risk resulting from ETS in
the workplace;
* to consider available studies addressing
these health outcomes and to evaluate the
validity of data for estimating risk from
occupational ETS exposure;
* to review and evaluate mathematical
models useful for estimating the risk due
to ETS exposure;
* to examine dose-response models and to
characterize the models regarding validity
and uncertainty in estimating health risk
attributable to ETS exposure in the
workplace.
The 1997 workshop evaluated the
accuracy of exposure measurement methods
for ETS and the utility ofvarious smoke con-
stituents as surrogates for measuring ETS
exposure; it also reviewed and evaluated math-
ematical models for predicting ETS concen-
trations (2). In their overall conclusions, the
workshop participants set out a general
approach for estimating the distribution of
ETS exposure in the United States (2). For a
quantitative risk assessment to be conducted,
information on the ETS exposure distribution
should be combined with estimates of the
exposure-effect relationships for the health
effects of interest (3). The Occupational
Safety and Health Administration had fol-
lowed a similar type ofgeneral approach in its
risk assessment in 1994 ofselected risks from
ETS exposure in theworkplace (4).
The evidence on adverse effects of ETS
has steadily increased over recent decades (5).
For adults the focus of this workshop-
causal associations have now been identified
between ETS exposure and lung cancer
(6-10) and also between ETS exposure and
ischemic heart disease (9-11). Some data
indicate other adverse effects of ETS in
adults, including increased risk for asthma
and respiratory symptoms and reduced lung
function level (5), but there is not yet enough
evidence to reach conclusions concerning
causality. Other health effects linked to ETS
exposure of adults include low birth weight
and increased risk for some nonrespiratory
cancers (5,9). This workshop was primarily
concerned with four health outcomes. Heart
disease and lung cancer were included
because a hazard has been identified. Asthma
was considered because ofits high prevalence
and the known responsiveness of persons
with asthma to inhaled pollutants. The expo-
sure of pregnant women was addressed
because of the potential vulnerability of
the fetus.
The charges given to workshop parti-
cipants in relation to the four health out-
comes are listed in Table 1. Workshop
participants were also asked to address key
methodologic issues that arise in interpreting
the epidemiologic data on ETS exposure and
in summarizing these data with meta-analysis.
Confounding has been of particular concern,
as exposure to ETS is now associated with
lifestyle risk factors in some populations.
Meta-analysis-combining summary esti-
mates from individual studies-has been
used to evaluate the hazard posed by ETS
and to quantitatively estimate the increased
risk associated with exposure. Questions have
been raised concerning the use of meta-
analysis generally and more specifically
regarding its application to studies of ETS.
This general topic was also included in the
scope ofthe workshop.
In this article we synthesize the informa-
tion presented in the workshop presentations
and in the related discussion. There was no
attempt to achieve group consensus on all
issues; consequently this summary should not
be construed as necessarily reflecting the views
ofall participants. The peer-reviewed articles
in this monograph are based on presentations
at this workshop. These papers as well as the
other presentations are summarized in the
following sections.
Exposure Assessment for the
Purposes of Health Risk
Assessment
The bridge from ETS exposure assessment
issues to those of health risk assessment (3)
was established at the outset of the work-
shop. Concepts of ETS exposure assessment
relevant for health risk assessment based on
human studies were presented and data on
ETS exposure levels in workplaces and resi-
dences were reviewed. The sources ofvaria-
tion in exposure, dose, and biologically
effective dose of ETS, as well as in individ-
ual susceptibility to the health effects, were
discussed and a model to describe them was
presented (3,12). A biologically driven
approach to select the most appropriate ETS
exposure assessment method for assessing
health risk was proposed. Special reference
was given to the diseases considered in the
workshop. This approach accounts for the
pathophysiology of the disease and the time
specificity of exposure and combines this
information with the time period that can
be assessed with different exposure assess-
ment methods. For example, an indicator of
short-term exposure is appropriate in studies
of asthma exacerbation, whereas an assess-
ment of cumulative exposure is relevant for
lung cancer.
The workshop emphasized that health
risk assessment requires two types ofexposure
assessment. First, an unbiased estimate ofthe
exposure-effect relation between ETS and the
health effect is needed, derived from health
effects studies that meet criteria for quality;
meta-analysis or pooled analysis can be used
to combine data from several studies.
Estimates ofthese relationships were the topic
of this workshop. Second, estimates of the
distribution of ETS levels in the workplaces
are needed if the occupational hazard due to
workplace ETS is the focus of the risk
assessment. These estimates were the focus of
the 1997 workshop.
There is no biologic or scientific basis for
expecting that the effects of ETS exposure in
the workplace would differ from the effects
related to home ETS exposure ifthe exposure
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What are important exposure assessment issues for health risk assessment based
on human studies ofworkplace ETS exposure?
Are there data available on markers of ETS exposure in the workplace?
Are there data on comparative levels of ETS exposure at home and work to support
extrapolation from studies ofspousal smoking?
Has workplace exposure to ETS been investigated as a risk factor for coronary
heart disease and other cardiovascular diseases?
Are quantitative risk estimates available?
Can the data on spouse smoking and coronary heart disease risk be extended
to workplace exposure?
Does the "healthy worker effect" have an impact on estimates of cardiovascular
disease risks arising from workplace ETS exposure?
Are there risk estimates that control for potential bias due to a) misclassification of
smoking status (some reported nonsmokers are actually smokers; and b)
confounding by lifestyle, e.g., diet and exercise?
Are there data available on biologically plausible mechanisms?
Are risk estimates available forworkplace exposure? What is the precision of such
estimates? What are the sources of uncertainty in extending them to current levels
of exposure?
Can the evidence on risks associated with spouse smoking be extended to the
workplace?
Are there any models of carcinogenesis useful for estimating workplace risks of
ETS exposure?
Are there data supporting a role for ETS in causing asthma in adults? Are there
data available related to workplace exposure?
Has ETS exposure been shown to exacerbate asthma in adults? What are the
findings of exposure ofvolunteers with asthma to ETS? Are there epidemiologic
data available on this issue?
What is the dose-response relationship for ETS exposure and low birth weight?
Are exposures in the workplace in a range of biologic concern?
Are there studies of occupational exposure to ETS and birth weight?
Can results from studies of birth weight and ETS exposure generally be extended to
the workplace?
is ofequal magnitude. Workplace exposures
likely are more variable than residential expo-
sures because oflarger variability in a) the size
and ventilation characteristics ofworkspaces,
b) the number ofsmoking co-workers, and c)
smoking policies in different workplaces.
However, median and mean indoor air con-
centrations ofETS markers, especially nico-
tine and respirable suspended particles, have
been found to be essentially comparable
between workplace and residential environ-
ments in the United States as well as in other
countries (3,8,13,14). Some work forces,
however, such as hospitality workers, may be
exposed to high levels ofETS that are rarely
encountered in residential settings.
Also at issue was how questionnaire-based
risk estimates should be combined with ETS
marker measurements used to assess the expo-
sure distribution when assessing the
proportion of disease cases attributable to
workplace ETS exposure. Some estimates of
the relationship between questionnaire-based
assessment of exposure and indoor ETS
marker concentrations have been provided by
experimental and field studies (15-19). More
research is recommended, however, to achieve
more precise estimates ofthese relationships
under different environmental conditions.
Cardiovascular Diseases
The charges concerning cardiovascular
diseases were broad (Table 1). The evidence
on spouse's smoking and heart diseases as well
as the studies ofworkplace exposure in partic-
ular were reviewed and key methodologic
questions including study population selec-
tion, exposure misclassification and con-
founding were addressed. In addition, data
on biologic mechanisms were discussed.
Usefulness of meta-analysis in estimating
coronary heart disease risk from workplace
ETS exposure and possibilities to model
exposure-effect relationships were also
addressed.
Chappell (20) presented a thorough
discussion on the use of meta-analysis in
estimating coronary heart disease risk from
workplace ETS exposure. Advantages as well
as potential problems in applying this analy-
tical technique to the available data were
discussed. Further suggestions on how to
improve the quality ofthe risk estimates by
adjusting for duration and intensity of expo-
sure to better reflect workplace conditions
were offered. As an alternative to meta-
analysis for estimating occupational risk,
Chappell also suggested the use ofastochastic
approach where distributional information
based on the available studies rather than sim-
ply on point estimates is considered.
The relationship of ETS exposure to
subclinical measures of the development of
atherosclerotic disease was addressed in a sepa-
rate presentation. B-mode real-time ultrasound
can be used to estimate the extent ofathero-
sclerosis noninvasively, offering the possibility
ofmeasuringsubclinical markers ofdisease; the
intimal-media thickness ofthe carotid artery
has been used as an index ofsystemic athero-
sclerosis. Howard and Wagenknecht (21)
described cross-sectional and longitudinal find-
ings from the Atherosclerosis Risk in
Communities (ARIC) study, which linked
ETS exposure to both greater thickness and an
accelerated rate ofincrease in thickness ofthe
intimal-media. This finding implies that ETS
exposure accelerates the process ofatheroscle-
rosis. Other measures ofsubclinical disease
considered in relation to ETS exposure
included decreased endothelial function and
silent cerebral infarction.
Several presentations covered the evidence
on ETS exposure and heart disease risk. Thun
and colleagues (22) carried out a meta-
analysis of 17 studies, 9 cohort and 8
case-control, on the risk of ischemic heart
disease for nonsmokers married to smokers.
The evidence, which encompassed more than
485,000 lifelong nonsmokers and 7,345
events, was substantially more extensive than
5 years earlier when the Occupational Safety
and Health Administration conducted its risk
assessment, using the estimate from only one
study conducted in Washington County,
Maryland (23). The meta-analysis provided
an overall estimate of relative risk of 1.25
(95% confidence interval [CI], 1.17-1.33).
Together, Thun and Howard (24)
considered the various types ofbias considered
to be potential explanations for the association
ofETS with ischemic heart disease. These pri-
marily include confounding and information
bias. There has been concern that bias may at
least partially explain the association because
the relative risk has been considered dispro-
portionatelyelevated in relation to relative risk
values for active smoking. Their analysis
indicated that the association cannot be
readily explained by bias. Additionally, they
described effects of acute exposure to ETS
that provide insight concerning mechanisms
that may underlie the association ofETS with
cardiovascular disease.
Information available on risk attributable
to workplace exposure was specifically
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addressed in two presentations. Kawachi and
Colditz (25) summarized the available evi-
dence from 5 studies, 3 case-control and 2
cohort. The point estimates ofrelative risk in
the individual studies ranged from 1.2 to 1.9,
but none of the estimates were statistically
significant. It was stated that because ofthe
imprecision of the risk estimates in all but
one study, a.modest increase in cardiovascular
disease risk from workplace exposure to ETS
could not be excluded. Additionally, in con-
trast to the evidence on spousal exposure to
ETS and increased risk ofcardiovascular dis-
ease, studies ofworkplace ETS exposure are
still sparse and further research is needed.
Steenland (26) set out an approach for con-
ducting a quantitative risk assessment of
workplace ETS. His approach uses a relative
risk estimate derived by meta-analysis. This
method leads to an estimate ofapproximately
340 excess ischemic heart disease deaths per
year among nonsmoking U.S. workers age 35
to 70 years.
Lung Cancer
A causal role of ETS in induction oflung
cancer is strongly established (7,8). Biologic
plausibility is derived from the fact that ETS
contains the same carcinogenic compounds as
mainstream smoke inhaled by active smokers.
The workshop charges on workplace ETS
exposure and lung cancer included a review
of estimates of lung cancer risk associated
with ETS exposure, with emphasis on work-
place ETS exposure. Several contributors
reviewed potential sources ofbias and con-
founding in studies ofETS and lung cancer
as well as the methods that have been applied
in the studies to reduce their impact. Finally,
different modeling approaches to assess the
lung cancer risk related to workplace ETS
exposure were reviewed.
Over 40 studies have examined the
relationship between spousal smoking and
risk oflung cancer. Many ofthem have pro-
vided evidence ofan exposure-response rela-
tionship with the number of cigarettes
smoked by the spouse and/or with the dura-
tion of ETS exposure at home or in the
workplace (27,28). The risk related specifi-
cally to workplace ETS exposure has been
studied in women in 16 hospital-based or
population-based case-control studies and in
men in 7 hospital-based or community-based
case-control studies and in 1 cohort study
(28,29). Most ofthe studies were not explic-
itly designed to evaluate the association
between workplace ETS and lung cancer risk
and consequently had low power to detect a
statistically significant relationship (28). In
general, the risk estimates appear to be con-
sistent with those for exposure from a smok-
ing spouse. Recent studies have had larger
sample sizes and addressed many of the
potential sources ofbias. These studies have
shown a statistically significant increase in
lung cancer risk related to workplace ETS
and have provided evidence ofincreasing risk
with increasing duration ofworkplace ETS
exposure (30-33).
A pooled analysis or meta-analysis of
individual studies can provide a useful
approach to combine data from small, individ-
ual studies to assess the risk. A meta-analysis is
often a more feasible approach, but it does not
provide an opportunity to assess heterogene-
ity of risk within subgroups, whereas a
pooled analysis ofraw data from studies usu-
ally offers greater flexibility in modeling (34).
Approaches to use the relatively large body of
data on the exposure-response relationship
between lung cancer risk and spouse's smok-
ing to assess risk related to workplace ETS
were discussed (34,35). The exposure-response
relationship between lung cancer and ETS
exposure due to spousal smoking among non-
smoking women, using the number ofciga-
rettes smoked by the husband as an indicator
for the amount of exposure, was evaluated
using a log-linear model by Brown (35). A
total of 14 studies contributed data to this
analysis. The model for all countries com-
bined predicted an excess risk oflung cancer
of 17% per 10 cigarettes/day (95% CI,
12-22%), and the excess risk from the United
States alone was 13% per 10 cigarettes/day
(95% CI, 5-21%). On the basis ofdata on
smoking habits in the two large cancer pre-
vention studies by the American Cancer
Society (36,37), the average number ofciga-
rettes smoked dailyby U.S. men was about 24
(35). Applying this value to the model, the
average excess risk oflung cancer in non-
smoking women due to spousal smoking was
33% (95% CI, 14-56%). According to
serum cotinine measurements in a large
national survey ofthe U.S. population (38),
the workplace ETS exposure ofnonsmoking
women is on average 42% ofthe home expo-
sure ofnonsmokingwomen. This corresponds
to an average exposure of 10 cigarettes/day
(35). When this average workplace ETS
exposure was used to assess the excess risk of
lung cancer in nonsmoking women, an esti-
mate of 13% was obtained. After adjustment
ofthe estimate for ETS exposure in the refer-
ence group for sources other than the work-
place exposure, the estimated excess risk is
19% (95% CI, 10-28%).
As alternative approaches, one can model
lung cancer risk in current and former smok-
ers and extrapolate the results to low levels
corresponding to ETS exposures or one can
model restricted data from light smokers
(34). The latter approach is more directly
applicable to the range ofexposures compara-
ble with typical ETS exposure settings. The
modeling based on data in current and
former smokers should first adjust for ETS
exposure in the reference group so that the
effect estimate is not diluted by increased risk
among ETS exposed nonsmokers. The
exposure-risk patterns from light active
smoking models do not indicate a threshold
level below which exposures would not be
expected to increase the risk of lung cancer
(34). Average ETS exposure in nonsmokers
has been estimated to be the equivalent of
actively smoking 0.1-2 cigarettes/day (8,34).
The risk ratio for smoking 0.5 cigarettes/day
ranges between 1.1 and 1.3 in models
restricted to light smokers only (34). The risk
estimate of lung cancer in relation to ETS
exposure is surprisingly consistent regardless
ofwhether the modeling approach uses data
on active smoking and extrapolates the esti-
mates to low levels or whether more direct
data on passive smoking are used.
Potential biases that might affect the risk
estimates from lung cancer studies were dis-
cussed extensively by workshop participants
(28,29,39,40). Hospital-based case-control
studies may be weakened by a selection bias if
recruitment ofcases or controls is related in
some way to ETS exposure. In recent years,
several population-based case-control studies
have been conducted to avoid this type of
bias (28). In epidemiologic studies, some
degree ofmisclassification ofexposure and of
outcome is likely to occur. In many of the
studies, ETS exposure was classified on the
basis ofsmoking by the spouse onlywhile not
capturing exposure from other sources,
although as adults people are usually exposed
from multiple ETS sources, including work-
place and social settings. Consequently, the
reference category classified as unexposed may
include persons who have experienced sub-
stantial ETS exposure, thus diluting the
obtained risk estimates (39).
In case-control studies, use of proxy
respondents (usually a family member) to give
information on exposures for lung cancer cases
who are very ill ordeceased maylead to greater
misdassification ofETS exposure among cases
compared to controls (28,29). However, infor-
mation on ETS exposure variables reported by
surrogate respondents has been found to agree
closely with that reported by the lung cancer
cases themselves. Studies comparing results in
total study populations with analysis limited to
cases interviewed in person have shown
essentiallysimilar results (28,29).
Recall bias can affect risk estimates ifcases
(or surrogates) consider ETS exposure as a
possible explanation for the disease (28). The
U.S. multicenter case-control study included
controls drawn from the general population
and controls recruited among patients with
primary colon carcinoma (41). The latter
control group was expected to be searching
for an explanation for their cancer in the
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same manner as lung cancer cases. The results
were consistent in case-control comparisons
regardless ofthe control group used.
Misclassification ofself-reported smoking
status is a concern, as some current and for-
mer smokers may report that they are never
smokers and are at higher risk for lung cancer
because of their smoking (39). The propor-
tion ofever smokers (current or formersmok-
ers) misclassified as never smokers has been
estimated to be small: 3-7% (8,27,42). On
the basis ofmeasurements ofurinary cotinine
with a cut-off point of 50 ng/mg creatinine
to indicate active smoking, the proportion of
active smokers among reported never smok-
ers was between 3 and 5% (30,43). Most of
the ever smokers misclassified as never smok-
ers have quit smoking and had smoked fewer
cigarettes than an average smoker (39). In
addition, although smoking spouses tend to
marry each other, this type of differential
misclassification of the smoking status does
not appear to be likely with respect to
workplace ETS exposure.
Women nonsmokers living with smokers
have been shown to differ from those living
with nonsmokers with respect to such disease
risk factors as lifestyle and socioeconomic sta-
tus (40). Whether the same factors are associ-
ated with workplace ETS exposure is unclear.
Most studies published since the mid-1980s
have adjusted for important potential con-
founders, although the set ofconfounders has
differed among the studies. Most have
accounted for some indicator of socio-
economic status, which can be seen as a sur-
rogate for many lifestyle factors, but the
possibility of residual confounding exists.
Several studies have adjusted for exposure to
other occupational hazards and for dietary
habits, including low fruit and vegetable con-
sumption and high saturated fat intake, and
have shown negligible confounding by these
factors ofthe relationship between ETS expo-
sure and lung cancer risk (27-29,35).
Modification ofeffects ofETS by other occu-
pational and indoor exposures has not been
studied (29). Potential synergism between
these exposures and ETS should be studied to
evaluate whether ETS is especially harmful in
theworkplace.
Asthma
Strong evidence exists for a causal role for
ETS in the development and exacerbation of
asthma in children (8,9). However, there are
only a few studies on ETS and adult asthma.
For asthma, the charges for the workshop
participants were to review data on the role of
ETS in causing asthma in adults, with special
emphasis on workplace exposure, and to
review data on effects ofETS on exacerbation
of asthma in both epidemiologic and
controlled exposure studies (44).
Only four studies ofETS and adult onset
asthma were identified (45-48). Two longi-
tudinal, one case-control, and one cross-
sectional studies all indicated that the risk of
adult asthma is increased in relation to ETS
exposure in general and in some instances
specifically in relation to workplace exposure.
Some methodological problems ofthe studies
were identified including potential recall bias
of exposures and bias in selection ofstudy
subjects (44). Only one epidemiologic study
had addressed the effects ofETS exposure on
exacerbation ofasthma in adults and found
increased emergency room visits, hospitaliza-
tions, medication use, and absence from work
among ETS-exposed asthmatics, compared
with unexposed asthmatic subjects (49). In
this study retrospective assessment of both
ETS exposure and outcomes raises the ques-
tion ofpotential recall bias. The published
epidemiologic studies suggest that ETS con-
tributes both to development and exacerba-
tion of asthma in adults, but definite
conclusions cannot be reached because of a
limited number of studies and potential
problems in theirdesign.
More relevant data are available from
controlled exposure studies in asthmatic and
healthy volunteers (44). The results have
been quite inconsistent, probably because of
different selection criteria ofsubjects, small
study samples, and different exposure peri-
ods. However, there is evidence of a sub-
group ofasthmatics who are sensitive to ETS
and respond to ETS exposure with symp-
toms, reduction in lung function, and
increase in bronchial hyperresponsiveness.
The determinants of this susceptibility are
not known.
The available although limited literature
on ETS in adults suggests that ETS may have
a significant impact on exacerbation of
asthma in adults, and further clinical and epi-
demiologic studies paying special attention to
design issues are needed.
Low Birth Weight
For low birth weight, the charge for the
workshop participants was to consider the full
spectrum of the evidence on ETS and the
growth ofthe fetus and to address the applica-
bility ofdata from outside the workplace to
pregnant women working outside the home.
Active smoking during pregnancy has
been causally associated with reduced birth-
weight. Misra and Nguyen (50) considered
ETS exposure and reduced birth weight. For
women ofchild-bearing age, the workplace is
a particularly important locus ofexposure.
The literature on ETS exposure generally
shows associations with adverse health effects
including reduced birth weight. These find-
ings were considered applicable in the
workplace setting.
Concluding Remarks
This workshop addressed four outcome
measures in relation toworkplace exposure to
ETS: lung cancer, ischemic heart disease,
asthma, and low birth weight. The focus was
on approaches for deriving quantitative risk
estimates for workplace ETS exposure. In
addition, cross-cutting issues were addressed
including sources of bias that may have
affected risk estimates and the use of meta-
analysis and mathematical modeling for syn-
thesis of the evidence. Although bias from
confounding and exposure misclassification is
a concern, the workshop participants found
little evidence that estimates ofETS risk are
substantially affectedby bias.
For lung cancer, data from three types of
studies are available that can be used to esti-
mate risk related to ETS exposure: a) active
smoking, particularly at lower levels ofdaily
consumption, b) ETS exposure at home, and
c) ETS exposure at work. Mathematical mod-
els for lung cancer risk from active smoking
can be developed and then applied with
extrapolation to ETS exposure levels.
Estimates from studies of ETS exposure in
the home can be extended to the workplace
by considering the relative exposures in the
two types oflocations. Finally, several studies,
particularly the large U.S. multicenter study
(30), provide risk estimates based directly on
reportedworkplace exposure.
For ischemic heart disease, there are now
numerous reports ofthe increased risk associ-
ated with ETS exposure at home. Evidence is
far more limited on ETS exposure at work.
However, a meta-analysis approach was pre-
sented for estimating the hazard posed to
workers by increased ischemic heart disease
risk from ETS exposure.
For asthma and low birth weight, only
limited evidence on workplace exposure to
ETS was available. Persons with asthma and
pregnant women are groups considered sus-
ceptible to effects of inhaled pollutants in
general. For children, ETS exposure at home
is well characterized as exacerbating asthma
and increasing medical morbidity. An effect
ofworkplace exposure on adults with asthma
is plausible, and experimental studies show
that some asthmatics are sensitive to ETS.
However, we need further investigation on
workplace exposure to ETS as a risk factor for
exacerbation ofasthma.
Active smoking by the mother reduces
infant birth weight, as does ETS exposure at
home, although to a much lesser degree than
active maternal smoking. On a biologic basis,
ETS exposures at home and at work would
be expected to have the same consequences
for birth weight. Consequently, exposure of
pregnant women to ETS in the workplace
was considered an outcome ofconcern, while
needing further investigation.
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In combination, the two workshops-the
1997 workshop on exposure assessment and
the 1998 workshop on health outcomes-
provide a framework for assessing the risks of
ETS exposure in the workplace. An approach
for assessment ofETS exposure was proposed
in the 1997 workshop. The 1998 workshop
added the needed complement of dose-
response assessment for lung cancer and
cardiovascular disease.
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